Skip to main content

WELLS FARGO & COMPANY/MN

Position in BGLC — BioNexus Gene Lab Corp

CIK 72971 SAN FRANCISCO, CA

Position in BGLC

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$2
New position
Shares Held
1
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Specialty Chemicals

Basic Materials · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $4,284,072,164 across 54 Specialty Chemicals names.

# Ticker Company Shares Value (USD) Open

All Filings in BGLC

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $2 1